A new research paper reframes the simulation hypothesis, asking whether reality could be simulated and what science can test.

Cornered in a part of Downtown Los Angeles swamped in contemporary art museums and performance centers, REDCAT has become a ...

The new major version with a new JIT compiler, a revised parallelization API, and a maturing type system paves the way for ...

The lack of gains in productivity from AI could stall adoption and burst the economic bubble. Is there a rational explanation?

Introduction Application of artificial intelligence (AI) tools in the healthcare setting gains importance especially in the domain of disease diagnosis. Numerous studies have tried to explore AI in ...

This list is meant to be both a quick guide and reference for further research into these topics. It's basically a summary of that comp sci course you never took or forgot about, so there's no way it ...

Abstract: Operational knowledge is one of the most valuable assets in a company, as it provides a strategic advantage over competitors and ensures steady and optimal operation in machines. An ...

Abstract: The high-definition map, explicitly designed for autonomous driving, is an essential core module. Existing mapping methods can not meet the unified coordinate system requirements, especially ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...